Therefore, they also represent pharmacological targets for the correction of endothelial dysfunction and the prevention of the progression of cardiovascular disease [63,64], as also demonstrated by the prevention of vascular complications in diabetic or hypertensive animals by endothelium-specific overexpression of GTPCH-I [11,65]. The gene discussed is GCH1; the disease is cardiovascular disorder.